Invention Grant
- Patent Title: Affinity peptides toward infliximab
- Patent Title (中): 针对英夫利昔单抗的亲和肽
-
Application No.: US14338391Application Date: 2014-07-23
-
Publication No.: US09248194B2Publication Date: 2016-02-02
- Inventor: Daphne Ann Salick Ryan , John Kehoe , John Wheeler , Chunlin Yang , Abla Creasy
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Kirk Baumeister
- Main IPC: A61K47/42
- IPC: A61K47/42 ; C07K16/24 ; A61K39/395 ; A61K39/00
Abstract:
We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab.
Public/Granted literature
- US20140328837A1 Affinity Peptides Toward Infliximab Public/Granted day:2014-11-06
Information query
IPC分类:
